BackgroundCardiovascular diseases are the major cause of death globally and represent a major economic burden on health care systems. Positive effects of disease management programs have been shown for patients with heart failure (HF). Remote monitoring and telemonitoring with active intervention are beneficial in atrial fibrillation (AF) and therapy-resistant hypertension (TRH), respectively. For these patients, we have developed a novel integrated care concept (NICC) which combines telemedicine with intensive support by a care center, including a call center, an integrated care network including inpatient and outpatient care providers and guideline therapy for patients.MethodsThe aim of the study is to demonstrate the superiority of NICC over guideline therapy alone. The trial is designed as open-label, bi-center, parallel-group design with two groups and a blinded observer. Patients will be included if they are either inpatients or if they are referred to the outpatient clinic of the hospitals by their treating physician. Randomization will be done individually with stratification by cardiovascular disease (AF, HF, TRH), center and admission type. Primary endpoints are based on the 1-year observation period after randomization. The first primary endpoint is the composite endpoint consisting of mortality, stroke and myocardial infarction. The number of hospitalizations form the second primary endpoint. The third primary endpoint is identical to the first primary endpoint plus cardiac decompensation. Adjustments for multiple testing are done using a fall-back strategy. Secondary endpoints include patient adherence, health care costs, quality of life, and safety. A sample size of 2930 gives 80% power at the two-sided 2.5% test level for the first primary endpoint. The power for the second primary endpoint is 99.8% at this sample size, and it is 80% with 1086 patients.DiscussionThis study will inform care providers whether quality of care can be improved by an integrated care concept providing telemedicine through a round-the-clock call center approach. We expect that cost of the NICC will be lower than standard care because of reduced hospitalizations. If the study has a positive result, NICC is planned to be immediately rolled out in the federal state of Mecklenburg-West Pomerania and other federal states in Germany. The trial will also guide additional research to disentangle the effects of this complex intervention.Trial registrationDRKS, ID: DRKS00013124. Registered on 5 October 2017;ClinicalTrials.gov, ID: NCT03317951. Registered on 17 October 2017.Electronic supplementary materialThe online version of this article (10.1186/s13063-018-2502-1) contains supplementary material, which is available to authorized users.
BestMastersMit "BestMasters" zeichnet Springer die besten Masterarbeiten aus, die an renommierten Hochschulen in Deutschland, Österreich und der Schweiz entstanden sind. Die mit Höchstnote ausgezeichneten Arbeiten wurden durch Gutachter zur Veröffentlichung empfohlen und behandeln aktuelle Themen aus unterschiedlichen Fachgebieten der Naturwissenschaften, Psychologie, Technik und Wirtschaftswissenschaften. Die Reihe wendet sich an Praktiker und Wissenschaftler gleichermaßen und soll insbesondere auch Nachwuchswissenschaftlern Orientierung geben.Weitere Bände in der Reihe
Chronisch erkrankt zu sein heißt, ein langfristig symptombehaftetes Leben mit vielen einzelnen Behandlungsepisoden, erbracht von vielen einzelnen Institutionen und Akteuren, zu führen. Das stellt unser Gesundheitssystem zunehmend auf die Probe. Dieser komplexe, langfristige und intersektorale Behandlungsbedarf, der vor allem verbesserten Lebensbedingungen und medizinischem Fortschritt geschuldet ist, war bei der Etablierung unseres Systems noch nicht in der aktuellen Ausprägung absehbar.
Derzeit vergeht kein Tag ohne Berichterstattung zum Thema Fachkräftemangel im Gesundheitswesenund dem Druck, der auf den verbleibenden Pflegefachkräften sowie deren Unterstützern lastet. Die Corona-Pandemie gibt uns also einen bitteren Vorgeschmack darauf, was in den kommenden zwei Jahrzehnten auf uns zukommen könnte, wenn mit der „Ressource“ Personal nicht nachhaltig umgegangen wird.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.